Cardiff Oncology (CRDF) Long-Term Debt Issuances (2013 - 2018)
Cardiff Oncology (CRDF) posted Long-Term Debt Issuances of $1.0 million for Q2 2018, up 566.67% sequentially from $156526.0 in Q1 2018, and up 566.67% YoY from $156526.0 in Q2 2017.
Cardiff Oncology (CRDF) Long-Term Debt Issuances (2013 - 2018) Analysis & Trends
Cardiff Oncology has reported Long-Term Debt Issuances for 5 years, with the latest figure at $1.0 million in Q2 2018.
- Quarterly Long-Term Debt Issuances rose 566.67% year-over-year to $1.0 million in Q2 2018, while the trailing twelve-month figure through Mar 2019 was $1.0 million (up 66.67% YoY) and the FY2020 annual result came in at $305000.0, changed N/A from the prior year.
- Long-Term Debt Issuances grew to $1.0 million in Q2 2018 per CRDF's latest filing, from $156526.0 in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $14.5 million in Q2 2014 and troughed at -$48637.0 in Q1 2014.
- A 4-year average of $1.5 million and a median of $156526.0 in 2017 frame the typical range for Long-Term Debt Issuances.
- The widest YoY moves for Long-Term Debt Issuances: up 566.67% in 2018, down 0.0% in 2018.
- Over 4 years, Long-Term Debt Issuances stood at $61277.0 in 2014, then fell by 14.85% to $52175.0 in 2016, then jumped by 200.0% to $156526.0 in 2017, then soared by 566.67% to $1.0 million in 2018.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $1.0 million, $156526.0, and $156526.0 for Q2 2018, Q1 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 1.04 Mn |
| Jun 30, 2018 | 1.04 Mn |
| Mar 31, 2018 | 156,526.00 |
| Mar 31, 2018 | 156,526.00 |
| Dec 31, 2017 | 156,526.00 |
| Dec 31, 2017 | 156,526.00 |
| Sep 30, 2017 | 156,526.00 |
| Sep 30, 2017 | 156,526.00 |
| Jun 30, 2017 | 156,526.00 |
| Jun 30, 2017 | 156,526.00 |
| Mar 31, 2017 | 156,526.00 |
| Mar 31, 2017 | 156,526.00 |
| Dec 31, 2016 | 52,175.00 |
| Dec 31, 2016 | 52,175.00 |
| Dec 31, 2014 | 61,277.00 |
| Dec 31, 2014 | 61,277.00 |
| Sep 30, 2014 | 515,964.00 |
| Sep 30, 2014 | 515,964.00 |
| Jun 30, 2014 | 14.47 Mn |
| Jun 30, 2014 | 14.47 Mn |